D.E. Shaw & Co’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.33M | Buy |
1,003,912
+280,695
| +39% | +$2.91M | 0.01% | 1793 |
|
|
2025
Q4 | $8.94M | Buy |
723,217
+402,050
| +125% | +$4.31M | ﹤0.01% | 1862 |
|
|
2025
Q3 | $2.83M | Sell |
321,167
-90,201
| -22% | -$702K | ﹤0.01% | 2706 |
|
|
2025
Q2 | $2.62M | Buy |
411,368
+139,094
| +51% | +$796K | ﹤0.01% | 2541 |
|
|
2025
Q1 | $1.32M | Sell |
272,274
-110,769
| -29% | -$917K | ﹤0.01% | 2899 |
|
|
2024
Q4 | $3.66M | Sell |
383,043
-388,095
| -50% | -$3.56M | ﹤0.01% | 2240 |
|
|
2024
Q3 | $6.44M | Sell |
771,138
-56,658
| -7% | -$515K | 0.01% | 1756 |
|
|
2024
Q2 | $5.65M | Buy |
827,796
+411,132
| +99% | +$1.77M | 0.01% | 1755 |
|
|
2024
Q1 | $1.05M | Sell |
416,664
-769,888
| -65% | -$1.74M | ﹤0.01% | 3062 |
|
|
2023
Q4 | $2.85M | Buy |
1,186,552
+250,034
| +27% | +$588K | ﹤0.01% | 2389 |
|
|
2023
Q3 | $3.18M | Sell |
936,518
-41,399
| -4% | -$229K | ﹤0.01% | 2212 |
|
|
2023
Q2 | $7.19M | Sell |
977,917
-385,863
| -28% | -$3.58M | 0.01% | 1610 |
|
|
2023
Q1 | $14.1M | Sell |
1,363,780
-267,838
| -16% | -$3.24M | 0.02% | 1114 |
|
|
2022
Q4 | $19.3M | Buy |
1,631,618
+639,405
| +64% | +$9.89M | 0.02% | 950 |
|
|
2022
Q3 | $20.8M | Sell |
992,213
-73,734
| -7% | -$2.05M | 0.02% | 822 |
|
|
2022
Q2 | $33.1M | Sell |
1,065,947
-97,639
| -8% | -$3.33M | 0.04% | 589 |
|
|
2022
Q1 | $47.8M | Buy |
1,163,586
+218,248
| +23% | +$9.63M | 0.04% | 511 |
|
|
2021
Q4 | $41.1M | Buy |
945,338
+882,893
| +1,414% | +$39.9M | 0.03% | 656 |
|
|
2021
Q3 | $3.13M | Buy |
62,445
+52,852
| +551% | +$3.2M | ﹤0.01% | 2586 |
|
|
2021
Q2 | $604K | Buy |
+9,593
| New | +$616K | ﹤0.01% | 3934 |
|
|
2021
Q1 | – | Sell |
-12,991
| Closed | -$1.16M | – | 4148 |
|
|
2020
Q4 | $1.16M | Buy |
+12,991
| New | +$1.19M | ﹤0.01% | 2928 |
|
|
2020
Q3 | – | Sell |
-7,954
| Closed | -$629K | – | 3914 |
|
|
2020
Q2 | $629K | Sell |
7,954
-37,703
| -83% | -$2.81M | ﹤0.01% | 3209 |
|
|
2020
Q1 | $2.64M | Sell |
45,657
-51,701
| -53% | -$2.98M | ﹤0.01% | 1954 |
|
|
2019
Q4 | $5.25M | Sell |
97,358
-17,857
| -15% | -$969K | 0.01% | 1692 |
|
|
2019
Q3 | $6.02M | Buy |
115,215
+76,298
| +196% | +$3.55M | 0.01% | 1507 |
|
|
2019
Q2 | $1.88M | Sell |
38,917
-26,555
| -41% | -$1.27M | ﹤0.01% | 2281 |
|
|
2019
Q1 | $3.31M | Sell |
65,472
-35,103
| -35% | -$2.07M | ﹤0.01% | 1812 |
|
|
2018
Q4 | $5.96M | Sell |
100,575
-24,998
| -20% | -$1.61M | 0.01% | 1412 |
|
|
2018
Q3 | $8.27M | Sell |
125,573
-15,254
| -11% | -$890K | 0.01% | 1228 |
|
|
2018
Q2 | $7.11M | Sell |
140,827
-38,420
| -21% | -$2M | 0.01% | 1299 |
|
|
2018
Q1 | $9.44M | Sell |
179,247
-66,332
| -27% | -$3.31M | 0.01% | 1036 |
|
|
2017
Q4 | $11.4M | Sell |
245,579
-51,702
| -17% | -$2.18M | 0.02% | 956 |
|
|
2017
Q3 | $12M | Sell |
297,281
-79,631
| -21% | -$2.88M | 0.02% | 832 |
|
|
2017
Q2 | $12.8M | Sell |
376,912
-28,399
| -7% | -$877K | 0.02% | 779 |
|
|
2017
Q1 | $11.8M | Sell |
405,311
-254,486
| -39% | -$7.75M | 0.02% | 811 |
|
|
2016
Q4 | $21.7M | Buy |
659,797
+126,148
| +24% | +$3.78M | 0.04% | 594 |
|
|
2016
Q3 | $16.8M | Sell |
533,649
-308,924
| -37% | -$8.98M | 0.03% | 651 |
|
|
2016
Q2 | $23.7M | Sell |
842,573
-49,303
| -6% | -$1.93M | 0.04% | 486 |
|
|
2016
Q1 | $32.4M | Buy |
891,876
+31,180
| +4% | +$1.1M | 0.06% | 383 |
|
|
2015
Q4 | $34.4M | Buy |
860,696
+98,910
| +13% | +$3.45M | 0.05% | 419 |
|
|
2015
Q3 | $21.7M | Buy |
761,786
+114,028
| +18% | +$3.76M | 0.03% | 586 |
|
|
2015
Q2 | $21.3M | Buy |
647,758
+40,339
| +7% | +$1.25M | 0.03% | 613 |
|
|
2015
Q1 | $17.5M | Buy |
607,419
+46,301
| +8% | +$1.33M | 0.03% | 651 |
|
|
2014
Q4 | $15.3M | Buy |
561,118
+40,642
| +8% | +$969K | 0.02% | 854 |
|
|
2014
Q3 | $11.1M | Buy |
520,476
+29,729
| +6% | +$681K | 0.01% | 1020 |
|
|
2014
Q2 | $11M | Buy |
490,747
+28,199
| +6% | +$657K | 0.02% | 1040 |
|
|
2014
Q1 | $11.7M | Sell |
462,548
-10,426
| -2% | -$263K | 0.02% | 955 |
|
|
2013
Q4 | $10.9M | Buy |
472,974
+4,904
| +1% | +$102K | 0.01% | 1081 |
|
|
2013
Q3 | $8.92M | Sell |
468,070
-32,756
| -7% | -$585K | 0.01% | 1101 |
|
|
2013
Q2 | $7.22M | Buy |
+500,826
| New | +$7.25M | 0.01% | 1095 |
|
Other funds holding EBS
VCM
PCM
VPM
D.E. Shaw & Co's EBS Position: Q1 2026 in Review
D.E. Shaw & Co increased its Emergent Biosolutions (EBS) stake by 39% in Q1 2026, buying an estimated $2.91M and bringing the position to 1,003,912 shares worth $8.33M. The position accounts for 0.01% of the portfolio, ranked #1793.
D.E. Shaw & Co first reported a position in EBS in Q2 2013 and has held it in 50 quarters since. The position peaked at $47.8M in Q1 2022. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- D.E. Shaw & Co held 1,003,912 shares of Emergent Biosolutions worth $8.33M as of Q1 2026.
- D.E. Shaw & Co bought 280,695 Emergent Biosolutions shares in Q1 2026, an estimated $2.91M.
- Emergent Biosolutions made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1793 holding.
- D.E. Shaw & Co first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 50 quarters since.
- D.E. Shaw & Co's Emergent Biosolutions position peaked at $47.8M in Q1 2022.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.